Anumana
Anumana, Inc. is a cardiac AI health-technology company founded as a joint venture between Mayo Clinic and nference, commercializing ECG-AI algorithms that read standard 10-second, 12-lead electrocardiograms to surface disease signals that are not visible to the human eye. Its portfolio includes the FDA-cleared ECG-AI LEF algorithm for detecting low ejection fraction in patients at risk of heart failure (trained on roughly 2.9 million ECG-echo pairs across 676,000+ patients), the first and only FDA-cleared ECG-AI algorithm for cardiac amyloidosis, and an FDA-cleared algorithm for early detection of pulmonary hypertension, plus a pipeline that includes hyperkalemia. Anumana is delivered as a regulated medical device that runs inside the customer's own ECG management system and EHR environment, ingesting digital waveform files and returning results into clinical workflow rather than being consumed as a public developer API.
Anumana is profiled on the APIs.io network. Tagged areas include Company, Health Care, Artificial Intelligence, Machine Learning, and Medical Devices.
Anumana’s developer surface includes documentation, support, engineering blog, FAQ, and 19 more developer resources.
Kin Score
Security Posture 3
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 2
Portal, sign-up, and the first successful call
Documentation 1
Reference material describing how the API behaves
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 5
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Other 4
Properties that don't map to a standard resource type